10-K: Wenyuan Group Corp. Reports 2025 Annual Results Amid Operational Shifts

Wenyuan Group Corp. reported a reduced net loss in 2025, driven by decreased operating expenses, despite a significant revenue decline and negative gross margins from cultural and health product sales.

Summary

• Net loss decreased to $639,043 in 2025 from $1,171,498 in 2024.
• Revenue declined by 59% to $24,627 in 2025 from $60,285 in 2024.
• Gross profit turned negative at $(14,162) in 2025, compared to $21,145 in 2024, primarily due to strategic sales of slow-moving inventory to related parties below historical cost.
• Operating expenses decreased by $228,840 to $640,735 in 2025, mainly due to lower professional fees and share-based compensation.
• The aquaculture product sales segment was discontinued in March 2024 due to lower-than-expected sales.
• The company faces substantial doubt about its ability to continue as a going concern due to recurring losses, a net capital deficiency, and cash outflow from operations.
• Lost control over an office suite in 2025 due to a legal auction related to a $271,673 guarantor liability.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as highly negative due to severe financial distress, including a significant revenue drop, negative gross margins, minimal cash, and a going concern warning, compounded by internal control weaknesses and high related-party transaction reliance.

Positives

• Reduced net loss from $1,171,498 in 2024 to $639,043 in 2025.
• Operating expenses decreased by $228,840 in 2025.
• Working capital deficit improved from $184,093 in 2024 to $40,870 in 2025.
• Cash used in operating activities decreased from $453,516 in 2024 to $197,571 in 2025.

Negatives

• Revenue declined by 59% from $60,285 in 2024 to $24,627 in 2025.
• Gross profit turned negative in 2025 at $(14,162), compared to a positive $21,145 in 2024, attributed to below-cost sales to related parties.
• The company has an accumulated deficit of $21,864,834 as of December 31, 2025.
• Net capital deficiency of $12,068 as of December 31, 2025.
• Cash balance significantly decreased to $144 as of December 31, 2025, from $27,208 in 2024.
• Lost control over an office suite in 2025 due to a legal auction related to a $271,673 guarantor liability.
• Identified significant deficiency in internal controls over financial reporting (lack of evidence for proper approval/review of disbursements) and material weaknesses (lack of segregation of duties).
• 100% of 2025 revenues derived from one related party.

Risks

• Investment in common stock is highly speculative, with risk of losing entire investment.
• Operations are entirely in China, subject to complex, rapidly evolving PRC laws and significant government oversight, which may change operations or stock value.
• Uncertainty in interpretation and enforcement of PRC laws, with potential for new laws to be costly, delay development, increase operating costs, or lead to penalties.
• PRC regulations on foreign investments by PRC residents (SAFE Circular 37, SAFE Notice 13) may subject beneficial owners or subsidiaries to liability, limit capital injection, or restrict profit distribution.
• Difficulty obtaining necessary government approvals for loans or capital contributions to PRC subsidiaries.
• Government control of currency conversion (SAFE Circular 19, SAFE Circular 16) may limit the ability to use Renminbi funds.
• Changes in China's economic, political, or social conditions or government policies could materially adversely affect business.
• Non-compliance with PRC labor-related laws and regulations may result in penalties.
• PRC laws governing business operations are sometimes vague and uncertain, limiting legal protections.
• Potential liability for improper use or appropriation of personal information under PRC privacy, data security, and cybersecurity laws (e.g., Cyber Security Law, Data Security Law, Personal Information Protection Law).
• Increased PRC government oversight on overseas securities offerings (CSRC Trial Administrative Measures) could limit or hinder ability to offer securities.
• Reliance on dividends from PRC subsidiaries for cash needs, with potential limitations on dividend payments or adverse tax implications.
• Changes in currency conversion rates between RMB and USD may affect investment value, with limited hedging options available.
• Potential classification as a PRC resident enterprise could result in unfavorable tax consequences, including a 25% enterprise income tax on worldwide income and withholding tax on dividends/gains for non-PRC shareholders.
• Changes in international trade policies, trade disputes, or trade wars could adversely affect business.
• U.S. regulatory bodies may be limited in their ability to conduct investigations or inspections of operations in China due to PRC state secrecy laws.
• Disclosures in SEC filings are not subject to the scrutiny of any PRC regulatory bodies.
• Additional and more stringent criteria for auditors of emerging market companies (HFCAA, PCAOB inspections) could lead to trading prohibitions or delisting if the company's auditor is deemed uninspectable.
• Failure to make adequate contributions to various employee benefit plans as required by PRC regulations may subject the company to penalties.
• Complex procedures for acquisitions of Chinese companies by foreign investors (M&A Rules, Anti-Monopoly Law) could make growth through acquisitions more difficult.
• Difficulties in effecting service of legal process, enforcing foreign judgments, or bringing actions in China against the company or its management.
• Uncertainty regarding indirect transfers of equity interests in PRC resident enterprises by non-PRC holding companies (SAT Bulletin 7, SAT Bulletin 37) could lead to tax obligations.
• Highly competitive cultural and health product market with many large companies.
• Substantial reliance on President Mr. Xizhen Ye; loss of key personnel could adversely affect the company.
• Public company requirements strain resources, divert management attention, and affect the ability to attract and retain qualified board members.
• Need for additional capital to support growth, which might not be available on acceptable terms and could lead to significant dilution.
• Difficulty establishing adequate management, legal, and financial controls in the PRC.
• Future issuance of additional common or preferred stock may have a dilutive effect on stockholders.
• No current intent to pay dividends; return on investment depends on stock price appreciation.
• Substantial costs to meet public company reporting requirements (estimated up to $100,000 per year).
• Common stock is likely to be subject to penny stock rules, which may decrease liquidity and price.

Future Outlook

The company intends to raise funds from the issuance of equity and/or debt securities to support its future success, which is dependent upon its ability to acquire or expand businesses with profitable operations and generate cash from operating activities. There is no assurance that additional funds will be available on acceptable terms, or at all.

Management Comments

• Our President, Mr. Ye is an excellent industry professional in the cultural and health product sales and project management and development field for more than 20 years. We believe he has the wealth of experience and contacts to help the Company to expand our business.
• We believe that we currently have a competitive advantage because of our experienced management team and marketing strategy.
• Management does not believe that any of these significant deficiencies materially affected the results and accuracy of its consolidated financial statements. However, in view of this discovery of such weaknesses, management has begun a review to improve them.
• Management is in the process of designing and implementing improvements in its internal control over financial reporting and we currently plan to hire an independent third-party consultant to assist in identifying and determining the appropriate accounting procedures and controls to implement.

Industry Context

StockSavvy.ai notes that Wenyuan Group Corp.'s pivot to cultural and health product sales, following the discontinuation of its aquaculture segment, positions it in a highly competitive market dominated by larger players. The company's reliance on its President's industry experience for expansion is a common strategy for smaller entities in niche markets, but the significant revenue decline and negative gross margins suggest challenges in establishing a strong competitive foothold. The ongoing issues with internal controls and the 'going concern' warning indicate fundamental operational and financial instability, contrasting with the growth seen in more established e-commerce and cultural product companies in China.

Comparison to Industry Standards

• The company's financial performance, including a 59% revenue decline and negative gross margins in 2025, falls significantly below industry standards for growth-oriented e-commerce and cultural product companies in China.
• Leading Chinese e-commerce platforms typically report robust revenue growth and healthy profit margins, unlike Wenyuan Group Corp.'s current results.
• The company's minimal cash balance of $144 and accumulated deficit of over $21 million indicate severe financial distress, far from the capital strength and liquidity seen in successful comparable businesses.
• The reliance on related party transactions for 100% of 2025 revenue also deviates from best practices for market-driven growth and raises governance concerns compared to globally benchmarked companies.

Management Changes

Corporate Governance

Legal Proceedings

• The company was sued by a creditor in 2024 due to a third-party default on a $271,673 (RMB 1,900,000) liability for which the company acted as a guarantor for an office suite.
• On October 22, 2024, The Shangcheng District People's Court of Hangzhou City, Zhejiang Province, ruled that Hangzhou Wenyuan is required to pay the creditor approximately $264,071 (RMB 1,900,000).
• During 2025, the office suite was forced for legal auction due to this litigation, and the company lost control over the property.

Related Party Transactions

• Offline product sales to Fang Zhang, a shareholder, totaled $24,627 in 2025, representing 100% of the company's revenues for the year.
• Accounts receivable from related parties were $28,597 as of December 31, 2025, which were subsequently collected in full during Q1 2026.
• The company incurred compensation expenses of $26,715 to the President (Mr. Xizhen Ye), $17,809 to his wife, and $23,152 to his daughter in 2025.
• Compensation payable to these related parties totaled $40,432 as of December 31, 2025.
• Loans due to the President remained at $5,575 as of December 31, 2025.
• Advances from the President's wife totaled $2,890 as of December 31, 2025, which are unsecured, non-interest-bearing, and due on demand.
• The company purchased inventory from Hangzhou Wenyuan Yiyun Media Co., Ltd., an entity controlled by the President's daughter, with $2,618 payable as of December 31, 2025.
• Gross margin for offline sales turned negative in 2025 primarily due to strategic sales of slow-moving and aged inventory to related parties at prices below historical cost, which were not conducted on an arms-length basis.

Stakeholder Impact

• Shareholders face significant dilution risk from future equity issuances, no planned dividends, and potential loss of investment due to 'going concern' issues and stock price volatility. The penny stock rules may also limit liquidity.
• Employees (5 in China) are subject to potential risks related to non-compliance with PRC labor laws.
• Customers may be impacted by the discontinuation of the aquaculture segment and the company's shift in product focus.
• Creditors face concerns regarding the company's ability to meet financial obligations, as evidenced by the net capital deficiency, recurring losses, and the office suite litigation.

Next Steps

• Management is in the process of evaluating cybersecurity needs and developing appropriate measures, including considering external cybersecurity experts, vulnerability assessments, and an incident response strategy.
• The Board will oversee any cybersecurity risk management framework, and a dedicated committee or officer will review and approve cybersecurity policies.
• Management is designing and implementing improvements in its internal control over financial reporting and plans to hire an independent third-party consultant to assist.
• The company intends to raise funds from the issuance of equity and/or debt securities.

Key Dates

Recommendation

A strong sell recommendation is warranted given the severe financial deterioration, including a 59% revenue decline, negative gross margins, and a critically low cash balance of $144. The 'going concern' warning, coupled with identified material weaknesses in internal controls and the loss of a key asset due to litigation, signals profound operational and financial instability. The heavy reliance on related-party transactions for revenue and below-cost sales further raises governance concerns. These factors present an exceptionally high risk profile with little to no clear path to sustainable profitability or liquidity, making the stock highly unattractive for investment.

Keywords

Wenyuan Group Corp, WYGC, SEC 10-K, Annual Report, Cultural Products, Health Products, E-commerce, China Operations, PRC Regulations, Going Concern, Related Party Transactions, Corporate Governance, Financial Performance, Shareholder Equity, Risk Factors, Auditor Inspection, Cybersecurity, Nevada Corporation